Home/Lodestone Biomedical/Sol Diamond, Ph.D.

SD

Sol Diamond, Ph.D.

Chief Technology Officer & Co-Founder

Lodestone Biomedical

Therapeutic Areas

Lodestone Biomedical Pipeline

Drug	Indication	Phase
IRIS Biosensor Platform	Preclinical Cancer Research & Drug Development	Research-Use-Only

Leadership Team at Lodestone Biomedical

Brendan Flynn, Ph.D.

Chief Executive Officer

View full Lodestone Biomedical profile